NCT06733675 - Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Healthy VolunteerPharmacokineticsSafetyDrug-Drug Interaction (DDI)FDC

Interventions

DRUG

Ledaborbactam etzadroxil

capsules

DRUG

Ceftibuten

capsules

DRUG

Ceftibuten-ledaborbactam etzadroxil

Fixed Dose Combination (FDC)

DRUG

Esomeprazole

40 mg capsule

Trial Locations (1)

ICON, Clinical Research Phase I Unit, Lenexa

All Listed Sponsors

collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Venatorx Pharmaceuticals, Inc.

INDUSTRY